AI assistant
Sending…
KEWAUNEE SCIENTIFIC CORP /DE/ — Director's Dealing 2014
Jul 17, 2014
34045_dirs_2014-07-17_eb12005e-5e9c-4086-ab35-25c8047db0cf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU)
CIK: 0000055529
Period of Report: 2014-07-16
Reporting Person: Rausch David M. (Director, President, CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-07-16 | Common Stock | M | 1250 | $10.64 | Acquired | 9075 | Direct |
| 2014-07-16 | Common Stock | M | 1000 | $8.59 | Acquired | 10075 | Direct |
| 2014-07-16 | Common Stock | F | 1247 | $17.55 | Disposed | 8828 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-07-16 | Option to Buy | $10.64 | M | 1250 | Disposed | 2020-08-25 | Common Stock (1250) | Direct |
| 2014-07-16 | Option to Buy | $8.59 | M | 1000 | Disposed | 2021-08-24 | Common Stock (1000) | Direct |
Footnotes
F1: Consideration for the exercise of the underlying option to buy was paid through a "net exercise" by directing the company to retain as payment for the total exercise cost a sufficient number of shares of Common Stock that would have been otherwise received upon this exercise as reported below on this Form 4 report.
F2: Employee stock option granted under Employee Stock Option plan under Rule 16b-3.
More from KEWAUNEE SCIENTIFIC CORP /DE/
Regulatory Filings
2026
May 1
Director's Dealing
2026
Mar 27
Interim / Quarterly Report
2026
Mar 13
Regulatory Filings
2026
Mar 11
Report Publication Announcement
2026
Feb 25
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Jan 8
Director's Dealing
2026
Jan 7
Director's Dealing
2026
Jan 2
Director's Dealing
2025
Dec 31